Your browser doesn't support javascript.
loading
In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation.
Krupar, Rosemarie; Watermann, Christian; Idel, Christian; Ribbat-Idel, Julika; Offermann, Anne; Pasternack, Helen; Kirfel, Jutta; Sikora, Andrew G; Perner, Sven.
Afiliação
  • Krupar R; Pathology of the Research Center Borstel, Leibniz Lung Center, Borstel, Germany. rkrupar@fz-borstel.de.
  • Watermann C; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany. rkrupar@fz-borstel.de.
  • Idel C; Pathology of the Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
  • Ribbat-Idel J; Department of Otorhinolaryngology, University Hospital Schleswig-Holstein, Luebeck, Germany.
  • Offermann A; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.
  • Pasternack H; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.
  • Kirfel J; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.
  • Sikora AG; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.
  • Perner S; Department of Otorhinolarygology - Head and Neck Surgery, Baylor College of Medicine, Houston, USA.
Sci Rep ; 10(1): 9389, 2020 06 10.
Article em En | MEDLINE | ID: mdl-32523042

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histona Acetiltransferases / Proteína p300 Associada a E1A / Carcinoma de Células Escamosas de Cabeça e Pescoço / Imunoterapia / Modelos Teóricos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histona Acetiltransferases / Proteína p300 Associada a E1A / Carcinoma de Células Escamosas de Cabeça e Pescoço / Imunoterapia / Modelos Teóricos Idioma: En Ano de publicação: 2020 Tipo de documento: Article